Takeda Pharmaceutical (TAK) Current Assets: 2018-2025

  • Takeda Pharmaceutical's Current Assets fell 4.28% to $16.5 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $16.5 billion, marking a year-over-year decrease of 4.28%. This contributed to the annual value of $16.6 billion for FY2025, which is 6.71% down from last year.
  • According to the latest figures from Q1 2025, Takeda Pharmaceutical's Current Assets is $16.5 billion, which was down 4.28% from $17.3 billion recorded in Q1 2024.
  • In the past 5 years, Takeda Pharmaceutical's Current Assets registered a high of $25.6 billion during Q1 2021, and its lowest value of $16.5 billion during Q1 2025.
  • For the 3-year period, Takeda Pharmaceutical's Current Assets averaged around $17.3 billion, with its median value being $17.3 billion (2024).
  • In the last 5 years, Takeda Pharmaceutical's Current Assets climbed by 13.01% in 2021 and then fell by 18.77% in 2023.
  • Quarterly analysis of 5 years shows Takeda Pharmaceutical's Current Assets stood at $25.6 billion in 2021, then dropped by 12.92% to $22.3 billion in 2022, then dropped by 18.77% to $18.1 billion in 2023, then fell by 4.76% to $17.3 billion in 2024, then fell by 4.28% to $16.5 billion in 2025.
  • Its Current Assets stands at $16.5 billion for Q1 2025, versus $17.3 billion for Q1 2024 and $18.1 billion for Q1 2023.